denkapparat Operations’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.5M Buy
1,984
+418
+27% +$316K 0.4% 59
2026
Q2
$976K Buy
1,566
+374
+31% +$255K 0.32% 110
2026
Q1
$921K Hold
1,192
– – 0.38% 91
2025
Q4
$920K Buy
1,192
+464
+64% +$315K 0.5% 57
2025
Q3
$409K Buy
+728
New +$412K 0.26% 156
2025
Q2
– Sell
-406
Closed -$257K – 267
2025
Q1
$257K Buy
+406
New +$279K 0.27% 168

Other funds holding REGN

denkapparat Operations's REGN Position: Q3 2026 in Review

denkapparat Operations increased its Regeneron Pharmaceuticals (REGN) stake by 27% in Q3 2026, buying an estimated $316K and bringing the position to 1,984 shares worth $1.5M. The position accounts for 0.4% of the portfolio, ranked #59.

denkapparat Operations first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. 1,423 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • denkapparat Operations held 1,984 shares of Regeneron Pharmaceuticals worth $1.5M as of Q3 2026.
  • denkapparat Operations bought 418 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $316K.
  • Regeneron Pharmaceuticals made up 0.4% of denkapparat Operations's portfolio in Q3 2026, its #59 holding.
  • denkapparat Operations first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 1,423 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on denkapparat Operations's 13F filing for Q3 2026, filed 9 Nov 2026.